Austin Regional Clinic (ARC) has participated in more than 50 clinical trials since 2016 through its Clinical Research program, working with Innovo Research to explore new ways to prevent, detect, or treat diseases for both pediatric and adult patients.
The clinic is currently enrolling participants for five studies related to vaccines and treatments. These include research on pediatric migraines, chronic kidney disease, and chronic hives. Previous research at ARC included vaccine trials for COVID-19, chicken pox, meningitis in adults and children; diagnosis studies on autism and lung cancer; as well as treatment studies for arthritis, eczema, chronic kidney disease, hot flashes, and flu.
ARC’s clinical trials investigate a range of conditions and examine new medications and therapies. Clinical trials can take years from start to finish due to the careful processes involved.
One ongoing study at ARC is focused on the multiple sclerosis (MS) medication BRIUMVI. This 96-week study is evaluating the drug’s effectiveness, safety profile, and patient tolerance over time. According to ARC researchers, this provides people living with MS in Central Texas local access to a possible new treatment option while helping understand its long-term effects.
Another recent trial at ARC looked into slowing the progression of chronic kidney disease (CKD). The Phase III study involved patients with CKD who also had high proteinuria—a sign of kidney damage—and found that a new approach reduced protein levels in urine while significantly slowing down disease progression.
“ARC has been serving the community for over 45 years. In addition to comprehensive, coordinated, primary, specialty, and surgical care, we are proud to find new ways to prevent and treat illness and disease, improve outcomes, and provide Central Texans with access to advanced medical treatment,” said Anas Daghestani, MD, President & CEO of ARC.
ARC’s collaboration with Innovo Research brings together 14 provider-led medical organizations across the United States. These nationwide studies involve millions of patients along with more than 150 physician-led teams investigating various health topics.
“Our partnership with Innovo Research allows ARC to expand healthcare innovation and cutting-edge research, offering patients in our community a unique value,” said Jacques Benun, MD, FAAP Principal Investigator at ARC. “I feel fortunate to be in a position where I can make a difference in advancing medicine while helping our patients achieve their health care goals.”
Austin Regional Clinic was founded by three Austin physicians in 1980. Today it serves over 700,000 residents across 36 locations in Central Texas cities by providing primary care as well as specialty services such as same-day appointments; telemedicine; after-hours clinics; nursing services through the night; radiology; lab services; MyChart patient portal access; and programs addressing specific health issues like Multiple Sclerosis or Inflammatory Bowel Disease (IBD).
The Austin Chamber of Commerce works on regional economic development initiatives by fostering business partnerships within the area according to its official website. It encourages growth by organizing events around innovation and supporting inclusive development according to its official website.
